Spago Nanomedical begins endometriosis study
6th December 2022 Uncategorised 0Clinical trial has received regulatory approval and involves endometriosis candidate SN132D
More: Spago Nanomedical begins endometriosis study
Source: News
Clinical trial has received regulatory approval and involves endometriosis candidate SN132D
More: Spago Nanomedical begins endometriosis study
Source: News
© 1994 - 2026 B.M. Pharmaceuticals